Loading…

Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii

Very few studies have examined drug susceptibility of , and they involve a limited number of strains. The purpose of this study was to determine drug susceptibility profiles of isolates representing a spectrum of species genotypes (subtypes) with two different methodologies, i.e., broth microdilutio...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrobial agents and chemotherapy 2018-04, Vol.62 (4)
Main Authors: Bakuła, Zofia, Modrzejewska, Magdalena, Pennings, Lian, Proboszcz, Małgorzata, Safianowska, Aleksandra, Bielecki, Jacek, van Ingen, Jakko, Jagielski, Tomasz
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a418t-d91cd123a725f15bb245dda0c87402fb0b9a51245e1175e8976c566537ebda5f3
cites cdi_FETCH-LOGICAL-a418t-d91cd123a725f15bb245dda0c87402fb0b9a51245e1175e8976c566537ebda5f3
container_end_page
container_issue 4
container_start_page
container_title Antimicrobial agents and chemotherapy
container_volume 62
creator Bakuła, Zofia
Modrzejewska, Magdalena
Pennings, Lian
Proboszcz, Małgorzata
Safianowska, Aleksandra
Bielecki, Jacek
van Ingen, Jakko
Jagielski, Tomasz
description Very few studies have examined drug susceptibility of , and they involve a limited number of strains. The purpose of this study was to determine drug susceptibility profiles of isolates representing a spectrum of species genotypes (subtypes) with two different methodologies, i.e., broth microdilution and Etest assays. To confirm drug resistance, drug target genes were sequenced. A collection of 85 isolates, including representatives of eight different subtypes (I to VI, I/II, and IIB) from eight countries, was used. Drug susceptibility against 13 and 8 antimycobacterial agents was tested by using broth microdilution and Etest, respectively. For drug-resistant or high-MIC isolates, eight structural genes ( , , , , , , , and ) and one regulatory region ( ) were PCR amplified and sequenced in the search for resistance-associated mutations. All isolates tested were susceptible to rifampin (RIF), amikacin (AMK), co-trimoxazole (SXT), rifabutin (RFB), moxifloxacin (MXF), and linezolid (LZD) according to the microdilution method. Resistance to ethambutol (EMB), ciprofloxacin (CIP), and clarithromycin (CLR) was found in 83 (97.7%), 17 (20%), and 1 (1.2%) isolate, respectively. The calculated concordance between the Etest and dilution method was 22.6% for AMK, 4.8% for streptomycin (STR), 3.2% for CLR, and 1.6% for RIF. For EMB, INH, and SXT, not even a single MIC value determined by one method equaled that by the second method. The only mutations disclosed were A2266C transversion at the gene (CLR-resistant strain) and A128G transition at the gene (strain with STR MIC of >64 mg/liter). In conclusion, eight drugs, including RIF, CLR, AMK, SXT, RFB, MXF, LZD, and ethionamide (ETO), showed high activity against isolates. Discrepancies of the results between the reference microdilution method and Etest preclude the use of the latter for drug susceptibility determination in Drug resistance in may have different genetic determinants than resistance to the same drugs in .
doi_str_mv 10.1128/AAC.01788-17
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5913922</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2002210037</sourcerecordid><originalsourceid>FETCH-LOGICAL-a418t-d91cd123a725f15bb245dda0c87402fb0b9a51245e1175e8976c566537ebda5f3</originalsourceid><addsrcrecordid>eNp1kU1v1DAQhi0Eokvhxhn5CBIpHieO4wvSagsFqRWIj7M1cZzFJbEX26m0_x6321b0wMnjmWfe0cxLyEtgJwC8e7deb04YyK6rQD4iK2Cqq1qh2sdkxVjbVk3HmiPyLKVLVv5CsafkiKumli2XK2JO47Kl35dk7C673k0u7-nXGMYS-S1FP9Az6212hp7abOPsPPqcaBjpTec3m1zK6I2lztOLvQk9msK5Zaa_0SdMzj0nT0ackn1x-x6Tnx8__Nh8qs6_nH3erM8rbKDL1aDADMBrlFyMIPqeN2IYkJlONoyPPesVCihJCyCF7ZRsjWhbUUvbDyjG-pi8P-juln62g7E-R5z0LroZ414HdPphxbtfehuutFBQK86LwOtbgRj-LDZlPbtymGlCb8OSNGeMc2CslgV9e0BNDClFO96PAaavfdHFF33ji4Zr_M0BxzRzfRmW6Msl_se--neNe-E70-q_P1iW5g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2002210037</pqid></control><display><type>article</type><title>Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii</title><source>PubMed Central Free</source><source>American Society for Microbiology Journals</source><creator>Bakuła, Zofia ; Modrzejewska, Magdalena ; Pennings, Lian ; Proboszcz, Małgorzata ; Safianowska, Aleksandra ; Bielecki, Jacek ; van Ingen, Jakko ; Jagielski, Tomasz</creator><creatorcontrib>Bakuła, Zofia ; Modrzejewska, Magdalena ; Pennings, Lian ; Proboszcz, Małgorzata ; Safianowska, Aleksandra ; Bielecki, Jacek ; van Ingen, Jakko ; Jagielski, Tomasz</creatorcontrib><description>Very few studies have examined drug susceptibility of , and they involve a limited number of strains. The purpose of this study was to determine drug susceptibility profiles of isolates representing a spectrum of species genotypes (subtypes) with two different methodologies, i.e., broth microdilution and Etest assays. To confirm drug resistance, drug target genes were sequenced. A collection of 85 isolates, including representatives of eight different subtypes (I to VI, I/II, and IIB) from eight countries, was used. Drug susceptibility against 13 and 8 antimycobacterial agents was tested by using broth microdilution and Etest, respectively. For drug-resistant or high-MIC isolates, eight structural genes ( , , , , , , , and ) and one regulatory region ( ) were PCR amplified and sequenced in the search for resistance-associated mutations. All isolates tested were susceptible to rifampin (RIF), amikacin (AMK), co-trimoxazole (SXT), rifabutin (RFB), moxifloxacin (MXF), and linezolid (LZD) according to the microdilution method. Resistance to ethambutol (EMB), ciprofloxacin (CIP), and clarithromycin (CLR) was found in 83 (97.7%), 17 (20%), and 1 (1.2%) isolate, respectively. The calculated concordance between the Etest and dilution method was 22.6% for AMK, 4.8% for streptomycin (STR), 3.2% for CLR, and 1.6% for RIF. For EMB, INH, and SXT, not even a single MIC value determined by one method equaled that by the second method. The only mutations disclosed were A2266C transversion at the gene (CLR-resistant strain) and A128G transition at the gene (strain with STR MIC of &gt;64 mg/liter). In conclusion, eight drugs, including RIF, CLR, AMK, SXT, RFB, MXF, LZD, and ethionamide (ETO), showed high activity against isolates. Discrepancies of the results between the reference microdilution method and Etest preclude the use of the latter for drug susceptibility determination in Drug resistance in may have different genetic determinants than resistance to the same drugs in .</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.01788-17</identifier><identifier>PMID: 29437627</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Antitubercular Agents ; Mycobacterium kansasii ; Mycobacterium tuberculosis ; Susceptibility</subject><ispartof>Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4)</ispartof><rights>Copyright © 2018 American Society for Microbiology.</rights><rights>Copyright © 2018 American Society for Microbiology. 2018 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a418t-d91cd123a725f15bb245dda0c87402fb0b9a51245e1175e8976c566537ebda5f3</citedby><cites>FETCH-LOGICAL-a418t-d91cd123a725f15bb245dda0c87402fb0b9a51245e1175e8976c566537ebda5f3</cites><orcidid>0000-0003-3343-6823 ; 0000-0002-0581-2003</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.asm.org/doi/pdf/10.1128/AAC.01788-17$$EPDF$$P50$$Gasm2$$H</linktopdf><linktohtml>$$Uhttps://journals.asm.org/doi/full/10.1128/AAC.01788-17$$EHTML$$P50$$Gasm2$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3188,27924,27925,52751,52752,52753,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29437627$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bakuła, Zofia</creatorcontrib><creatorcontrib>Modrzejewska, Magdalena</creatorcontrib><creatorcontrib>Pennings, Lian</creatorcontrib><creatorcontrib>Proboszcz, Małgorzata</creatorcontrib><creatorcontrib>Safianowska, Aleksandra</creatorcontrib><creatorcontrib>Bielecki, Jacek</creatorcontrib><creatorcontrib>van Ingen, Jakko</creatorcontrib><creatorcontrib>Jagielski, Tomasz</creatorcontrib><title>Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii</title><title>Antimicrobial agents and chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Very few studies have examined drug susceptibility of , and they involve a limited number of strains. The purpose of this study was to determine drug susceptibility profiles of isolates representing a spectrum of species genotypes (subtypes) with two different methodologies, i.e., broth microdilution and Etest assays. To confirm drug resistance, drug target genes were sequenced. A collection of 85 isolates, including representatives of eight different subtypes (I to VI, I/II, and IIB) from eight countries, was used. Drug susceptibility against 13 and 8 antimycobacterial agents was tested by using broth microdilution and Etest, respectively. For drug-resistant or high-MIC isolates, eight structural genes ( , , , , , , , and ) and one regulatory region ( ) were PCR amplified and sequenced in the search for resistance-associated mutations. All isolates tested were susceptible to rifampin (RIF), amikacin (AMK), co-trimoxazole (SXT), rifabutin (RFB), moxifloxacin (MXF), and linezolid (LZD) according to the microdilution method. Resistance to ethambutol (EMB), ciprofloxacin (CIP), and clarithromycin (CLR) was found in 83 (97.7%), 17 (20%), and 1 (1.2%) isolate, respectively. The calculated concordance between the Etest and dilution method was 22.6% for AMK, 4.8% for streptomycin (STR), 3.2% for CLR, and 1.6% for RIF. For EMB, INH, and SXT, not even a single MIC value determined by one method equaled that by the second method. The only mutations disclosed were A2266C transversion at the gene (CLR-resistant strain) and A128G transition at the gene (strain with STR MIC of &gt;64 mg/liter). In conclusion, eight drugs, including RIF, CLR, AMK, SXT, RFB, MXF, LZD, and ethionamide (ETO), showed high activity against isolates. Discrepancies of the results between the reference microdilution method and Etest preclude the use of the latter for drug susceptibility determination in Drug resistance in may have different genetic determinants than resistance to the same drugs in .</description><subject>Antitubercular Agents</subject><subject>Mycobacterium kansasii</subject><subject>Mycobacterium tuberculosis</subject><subject>Susceptibility</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kU1v1DAQhi0Eokvhxhn5CBIpHieO4wvSagsFqRWIj7M1cZzFJbEX26m0_x6321b0wMnjmWfe0cxLyEtgJwC8e7deb04YyK6rQD4iK2Cqq1qh2sdkxVjbVk3HmiPyLKVLVv5CsafkiKumli2XK2JO47Kl35dk7C673k0u7-nXGMYS-S1FP9Az6212hp7abOPsPPqcaBjpTec3m1zK6I2lztOLvQk9msK5Zaa_0SdMzj0nT0ackn1x-x6Tnx8__Nh8qs6_nH3erM8rbKDL1aDADMBrlFyMIPqeN2IYkJlONoyPPesVCihJCyCF7ZRsjWhbUUvbDyjG-pi8P-juln62g7E-R5z0LroZ414HdPphxbtfehuutFBQK86LwOtbgRj-LDZlPbtymGlCb8OSNGeMc2CslgV9e0BNDClFO96PAaavfdHFF33ji4Zr_M0BxzRzfRmW6Msl_se--neNe-E70-q_P1iW5g</recordid><startdate>20180401</startdate><enddate>20180401</enddate><creator>Bakuła, Zofia</creator><creator>Modrzejewska, Magdalena</creator><creator>Pennings, Lian</creator><creator>Proboszcz, Małgorzata</creator><creator>Safianowska, Aleksandra</creator><creator>Bielecki, Jacek</creator><creator>van Ingen, Jakko</creator><creator>Jagielski, Tomasz</creator><general>American Society for Microbiology</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3343-6823</orcidid><orcidid>https://orcid.org/0000-0002-0581-2003</orcidid></search><sort><creationdate>20180401</creationdate><title>Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii</title><author>Bakuła, Zofia ; Modrzejewska, Magdalena ; Pennings, Lian ; Proboszcz, Małgorzata ; Safianowska, Aleksandra ; Bielecki, Jacek ; van Ingen, Jakko ; Jagielski, Tomasz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a418t-d91cd123a725f15bb245dda0c87402fb0b9a51245e1175e8976c566537ebda5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antitubercular Agents</topic><topic>Mycobacterium kansasii</topic><topic>Mycobacterium tuberculosis</topic><topic>Susceptibility</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bakuła, Zofia</creatorcontrib><creatorcontrib>Modrzejewska, Magdalena</creatorcontrib><creatorcontrib>Pennings, Lian</creatorcontrib><creatorcontrib>Proboszcz, Małgorzata</creatorcontrib><creatorcontrib>Safianowska, Aleksandra</creatorcontrib><creatorcontrib>Bielecki, Jacek</creatorcontrib><creatorcontrib>van Ingen, Jakko</creatorcontrib><creatorcontrib>Jagielski, Tomasz</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial agents and chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bakuła, Zofia</au><au>Modrzejewska, Magdalena</au><au>Pennings, Lian</au><au>Proboszcz, Małgorzata</au><au>Safianowska, Aleksandra</au><au>Bielecki, Jacek</au><au>van Ingen, Jakko</au><au>Jagielski, Tomasz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii</atitle><jtitle>Antimicrobial agents and chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2018-04-01</date><risdate>2018</risdate><volume>62</volume><issue>4</issue><issn>0066-4804</issn><eissn>1098-6596</eissn><abstract>Very few studies have examined drug susceptibility of , and they involve a limited number of strains. The purpose of this study was to determine drug susceptibility profiles of isolates representing a spectrum of species genotypes (subtypes) with two different methodologies, i.e., broth microdilution and Etest assays. To confirm drug resistance, drug target genes were sequenced. A collection of 85 isolates, including representatives of eight different subtypes (I to VI, I/II, and IIB) from eight countries, was used. Drug susceptibility against 13 and 8 antimycobacterial agents was tested by using broth microdilution and Etest, respectively. For drug-resistant or high-MIC isolates, eight structural genes ( , , , , , , , and ) and one regulatory region ( ) were PCR amplified and sequenced in the search for resistance-associated mutations. All isolates tested were susceptible to rifampin (RIF), amikacin (AMK), co-trimoxazole (SXT), rifabutin (RFB), moxifloxacin (MXF), and linezolid (LZD) according to the microdilution method. Resistance to ethambutol (EMB), ciprofloxacin (CIP), and clarithromycin (CLR) was found in 83 (97.7%), 17 (20%), and 1 (1.2%) isolate, respectively. The calculated concordance between the Etest and dilution method was 22.6% for AMK, 4.8% for streptomycin (STR), 3.2% for CLR, and 1.6% for RIF. For EMB, INH, and SXT, not even a single MIC value determined by one method equaled that by the second method. The only mutations disclosed were A2266C transversion at the gene (CLR-resistant strain) and A128G transition at the gene (strain with STR MIC of &gt;64 mg/liter). In conclusion, eight drugs, including RIF, CLR, AMK, SXT, RFB, MXF, LZD, and ethionamide (ETO), showed high activity against isolates. Discrepancies of the results between the reference microdilution method and Etest preclude the use of the latter for drug susceptibility determination in Drug resistance in may have different genetic determinants than resistance to the same drugs in .</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>29437627</pmid><doi>10.1128/AAC.01788-17</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-3343-6823</orcidid><orcidid>https://orcid.org/0000-0002-0581-2003</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0066-4804
ispartof Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4)
issn 0066-4804
1098-6596
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5913922
source PubMed Central Free; American Society for Microbiology Journals
subjects Antitubercular Agents
Mycobacterium kansasii
Mycobacterium tuberculosis
Susceptibility
title Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T21%3A08%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug%20Susceptibility%20Profiling%20and%20Genetic%20Determinants%20of%20Drug%20Resistance%20in%20Mycobacterium%20kansasii&rft.jtitle=Antimicrobial%20agents%20and%20chemotherapy&rft.au=Baku%C5%82a,%20Zofia&rft.date=2018-04-01&rft.volume=62&rft.issue=4&rft.issn=0066-4804&rft.eissn=1098-6596&rft_id=info:doi/10.1128/AAC.01788-17&rft_dat=%3Cproquest_pubme%3E2002210037%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a418t-d91cd123a725f15bb245dda0c87402fb0b9a51245e1175e8976c566537ebda5f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2002210037&rft_id=info:pmid/29437627&rfr_iscdi=true